P A van Veelen
Overview
Explore the profile of P A van Veelen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
686
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Madunic K, Luijkx Y, Mayboroda O, Janssen G, van Veelen P, Strijbis K, et al.
Mol Cell Proteomics
. 2023 Jan;
22(3):100501.
PMID: 36669592
Gut microbiota of the gastrointestinal tract provide health benefits to the human host via bacterial metabolites. Bacterial butyrate has beneficial effects on intestinal homeostasis and is the preferred energy source...
2.
Venema W, Hiddingh S, Janssen G, Ossewaarde-van Norel J, van Loon N, de Boer J, et al.
Clin Immunol
. 2022 Dec;
247:109219.
PMID: 36581221
Background: HLA-A29-positive birdshot chorioretinitis (BCR) is an inflammatory eye disorder that is generally assumed to be caused by an autoimmune response to HLA-A29-presented peptides from retinal arrestin (SAG), yet the...
3.
Tuerlings M, Janssen G, Boone I, van Hoolwerff M, Rodriguez Ruiz A, Houtman E, et al.
Osteoarthritis Cartilage
. 2022 Oct;
31(1):39-48.
PMID: 36208715
Objective: To explore the co-expression network of the osteoarthritis (OA) risk gene WWP2 in articular cartilage and study cartilage characteristics when mimicking the effect of OA risk allele rs1052429-A on...
4.
Kissel T, Reijm S, Slot L, Cavallari M, Wortel C, Vergroesen R, et al.
Ann Rheum Dis
. 2020 Feb;
79(4):472-480.
PMID: 32041746
Objective: Autoantibodies against antigens carrying distinct post-translational modifications (PTMs), such as citrulline, homocitrulline or acetyllysine, are hallmarks of rheumatoid arthritis (RA). The relation between these anti-modified protein antibody (AMPA)-classes is...
5.
Lubbers R, Oostindie S, Dijkstra D, Parren P, Verheul M, Abendstein L, et al.
Clin Exp Immunol
. 2019 Dec;
200(1):1-11.
PMID: 31853959
Carbamylation is a post-translational modification that can be detected on a range of proteins, including immunoglobulin (Ig)G, in several clinical conditions. Carbamylated IgG (ca-IgG) was reported to lose its capacity...
6.
Verheul M, van Veelen P, van Delft M, de Ru A, Janssen G, Rispens T, et al.
Autoimmun Rev
. 2017 Dec;
17(2):136-141.
PMID: 29203292
Carbamylation and citrullination are both post-translational modifications against which (auto)antibodies can be detected in sera of rheumatoid arthritis (RA) patients. Carbamylation is the chemical modification of a lysine into a...
7.
McLaughlin R, de Haan A, Zaldumbide A, de Koning E, de Ru A, van Veelen P, et al.
Clin Exp Immunol
. 2016 Feb;
185(2):133-40.
PMID: 26861694
The initiation of type 1 diabetes (T1D) requires a break in peripheral tolerance. New insights into neoepitope formation indicate that post-translational modification of islet autoantigens, for example via deamidation, may...
8.
Eichmann M, de Ru A, van Veelen P, Peakman M, Kronenberg-Versteeg D
Tissue Antigens
. 2014 Aug;
84(4):378-88.
PMID: 25154780
Research on CD8 T cell-mediated inflammatory diseases requires a better understanding of target epitopes and the constraints placed upon these by major histocompatibility complex (MHC) class I binding restrictions, especially...
9.
Otte S, van de Meent E, van Veelen P, Pundsnes A, Amesz J
Photosynth Res
. 2013 Dec;
35(2):159-69.
PMID: 24318682
The chlorosomal bacteriochlorophyll (BChl) composition of the green sulfur bacteria Chlorobium vibrioforme and Chlorobium phaeovibrioides was investigated by means of normal-phase high-performance liquid chromatography. From both species a number of...
10.
van de Kooij B, Rooswinkel R, Kok F, Herrebout M, de Vries E, Paauwe M, et al.
Oncogene
. 2013 Apr;
32(48):5439-48.
PMID: 23563182
Anti-apoptotic Bcl-2 family members can contribute to tumorigenesis and may convey resistance to anti-cancer regimens. Therefore, they are important targets for novel therapeutics, particularly Bcl-2 homology (BH)3 mimetics. Bcl-B (BCL-2-like...